Xcout Intel
Ambros Therapeutics
Ambros Therapeutics is a clinical-stage biotechnology company headquartered in Irvine, California, focused on the development of innovative therapeutics.
Subscribe to see Ambros Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ambros Therapeutics at a glance
Ambros Therapeutics is a biotechnology company headquartered in United States. Its most recent funding round, Series A, raised $125M in December 2025. Xcout tracks 2 named people at Ambros Therapeutics, including Jay Hagan (Chief Executive Officer).
Ambros Therapeutics leadership
- Jay HaganChief Executive Officer
- Keith KatkinCo-Founder and Chairman
Ambros Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $125M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Ambros Therapeutics news
Investors
Ambros Therapeutics competitors
A few of Ambros Therapeutics's closest competitors — see the full list of competitors and alternatives →
Novus Therapeutics, Inc. is a clinical-stage public biotechnology company headquartered in Irvine, California, focused on the acquisition and development of pharmaceutical and therapeutic products.
C3J Therapeutics, Inc. is a clinical-stage biotechnology company based in Los Angeles, California, focused on improving human health through the development of targeted antimicrobials.
Rubedo Life Sciences is a clinical-stage biopharmaceutical company headquartered in Sunnyvale and Mountain View, California, developing a broad portfolio of innovative therapies.
BreStem Therapeutics, Inc. is a clinical-stage biotechnology company located in Raleigh, North Carolina, focused on developing novel therapeutics to fight various diseases.
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company located in Mission Viejo, California, focused on developing a platform of compounds for biodefense and fibrosis applications.
PhaseBio Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Malvern, Pennsylvania, with additional operations in San Diego, California. The company focuses on the discovery and development of novel biopharmaceuticals for cardiovascular and other severe diseases.
Get Ambros Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ambros Therapeutics in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access